[Hematological toxicity and nandrolone decanoate during polychemotherapy of bronchogenic carcinoma. Preliminary note].
作者信息
de Sanctis C, De Luca S, Succi A, Gargiulo P, Mugnaini L, Antilli A, Signora M, Cruciani A R
出版信息
Clin Ter. 1986 Aug 15;118(3):183-6.
PMID:3757462
Abstract
摘要
相似文献
1
[Hematological toxicity and nandrolone decanoate during polychemotherapy of bronchogenic carcinoma. Preliminary note].
Clin Ter. 1986 Aug 15;118(3):183-6.
2
Effect of nandrolone phenpropionate on myelopoiesis.苯丙酸诺龙对骨髓生成的影响。
J Med. 1974;5(6):303-9.
3
Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer.
Cancer. 1986 Jul 1;58(1):183-6. doi: 10.1002/1097-0142(19860701)58:1<183::aid-cncr2820580131>3.0.co;2-3.
4
[Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].[基于顺铂的多药化疗在非小细胞支气管肺癌中的益处。九州肺癌化疗研究组]
Gan To Kagaku Ryoho. 1988 Jun;15(6):1901-8.
5
[Chemotherapy of advanced non-small cell bronchogenic carcinoma with cisplatin and vindesine].顺铂与长春地辛联合治疗晚期非小细胞支气管肺癌
Onkologie. 1984 Aug;7(4):202-4. doi: 10.1159/000215439.
6
Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.顺铂、长春地辛、阿霉素及环磷酰胺治疗非小细胞支气管肺癌
J Chemother. 1989 Jul;1(4 Suppl):1205-6.
7
Phase II trial of cyclophosphamide and cis-platinum for non-small cell bronchogenic carcinoma.环磷酰胺和顺铂用于非小细胞支气管源性癌的II期试验。
Am J Clin Oncol. 1984 Dec;7(6):725-7. doi: 10.1097/00000421-198412000-00023.
8
[Value of polychemotherapy for bronchogenic carcinoma other than undifferentiated small cell carcinoma].
Union Med Can. 1984 Mar;113(3):222-4.
9
Chronic, supra-physiological doses of nandrolone decanoate and exercise induced cardio-toxicity in an animal-model study.
Acta Physiol (Oxf). 2013 Jun;208(2):141-3. doi: 10.1111/apha.12093. Epub 2013 Apr 15.
10
[Bronchial cancer: possibilities and limits of chemotherapy. 2: Non-small cell bronchial cancer].[支气管癌：化疗的可能性与局限性。2：非小细胞支气管癌]
Fortschr Med. 1985 May 2;103(17):453-6.
Zotero 插件